SHIELD Lab (@bgauthierlab) 's Twitter Profile
SHIELD Lab

@bgauthierlab

Strategic Healing and Immuno-Endocrine Division led by BGauthier at @cabimer @FProgresoysalud. With @BreakthroughT1D, @diabetes_CERO @ciberdem

ID: 1854920871988576256

linkhttps://www.cabimer.es/en/research-groups/pancreatic-islet-development-regeneration/ calendar_today08-11-2024 16:16:46

62 Tweet

71 Takipçi

419 Takip Edilen

Hao Yin (@haoyin20) 's Twitter Profile Photo

CellMarker 2.0 An updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data http://117.50.127.228/CellMarker/index.html A nice resource for cell type markers for supervised clustering😁 Nucleic Acids Res 2023 academic.oup.com/nar/article/51…

CellMarker 2.0
An updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data

http://117.50.127.228/CellMarker/index.html

A nice resource for cell type markers for supervised clustering😁

<a href="/NAR_Open/">Nucleic Acids Res</a> 2023
academic.oup.com/nar/article/51…
Fundación DiabetesCERO (@diabetes_cero) 's Twitter Profile Photo

Coming Soon: Frontiers in T1D Cure 2025 2 grants of up to €100,000 to fund innovative research to cure type 1 diabetes. Applications open soon. Stay tuned & share! #Type1Diabetes #ResearchFunding #DiabetesCERO

Coming Soon: Frontiers in T1D Cure 2025

2 grants of up to €100,000 to fund innovative research to cure type 1 diabetes.

Applications open soon. Stay tuned &amp; share!

#Type1Diabetes #ResearchFunding #DiabetesCERO
Fundación Progreso y Salud (@fprogresoysalud) 's Twitter Profile Photo

La Fundación Fundación DiabetesCERO lanza la convocatoria internacional 'Frontiers in T1D Cure 2025', una iniciativa para impulsar proyectos de #diabetes tipo 1. Se otorgarán dos ayudas de 100.000 € a investigadores consolidados con enfoque traslacional lc.cx/7gr0EV

SED Diabetes (@sediabetes) 's Twitter Profile Photo

Fundación DiabetesCERO lanza la primera convocatoria internacional «Frontiers in T1D Cure 2025», una iniciativa destinada a financiar proyectos innovadores de investigación biomédica centrados en encontrar una cura para la #diabetestipo1. Se concederán dos becas de 100.000 €

Cabimer (@cabimer) 's Twitter Profile Photo

Twelve (12) research projects have been awarded to Cabimer researchers in the #PID2024 call for circa 3.5M€, Including 4 PhD #FPI contracts, to continue pursuing breakthroughs in Science! Stay tuned!

Prof Inés Pineda-Torra 🇪🇺🇪🇸🇺🇦 (@inespinedatorra) 's Twitter Profile Photo

To all #NuclearReceptors researchers! I’m Team Lead for this topic, and currently planning NR sessions for #ENDO2026 in Chicago. 📌If you have unpublished or recently published exciting data that you’d like to share please get in touch! 📌Specially ECRs and underrepresented Rs

Pancreatic Cell News (@pancreaticcell) 's Twitter Profile Photo

Researchers suggest that mitochondrial-encoded MOTS-c regulate pancreatic islet cell #senescence and that MOTS-c could act as a senotherapeutic agent to prevent pancreatic islet cell senescence and diabetes progression. 👉 go.nature.com/47h2B22

Researchers  suggest that mitochondrial-encoded MOTS-c regulate pancreatic islet cell #senescence and that MOTS-c could act as a senotherapeutic agent to prevent pancreatic islet cell senescence and diabetes progression.

👉 go.nature.com/47h2B22
SHIELD Lab (@bgauthierlab) 's Twitter Profile Photo

🌟 Passionate about immunology & diabetes research? Want to do a PhD in Seville, Spain? ☀️🧬 Join our lab at CABIMER to study immune–islet crosstalk & α→β cell transdifferentiation in Type 1 Diabetes 🩺 📩 Apply by email: [email protected]

SHIELD Lab (@bgauthierlab) 's Twitter Profile Photo

🏆Honored to coordinate a new Breakthrough T1D project with @DiabetesCERO, Life Length, Hospital Virgen Macarena, Biobanco del SSPA, Hospital Puerta de Hierro. 📍From Cabimer, @FPSalud & Junta de Andalucía, advancing early T1D detection and telomere research. ✨ share.google/hNUfUfy7jGAvzU…

Fundación Progreso y Salud (@fprogresoysalud) 's Twitter Profile Photo

Se trata de un trabajo liderado por nuestro científico Benoit Gauthier en Cabimer y que contempla, además, un programa piloto para la detección temprana de de la enfermedad en fases presintomáticas en personas de alto riesgo

SHIELD Lab (@bgauthierlab) 's Twitter Profile Photo

Great pleasure to host Joaquin Dopazo from Fundación Progreso y Salud at Cabimer last Friday! 🚀 An inspiring talk on how AI is reshaping targeted drug discovery. #AI #DrugDiscovery #Innovation Are we obsolete?? Don't think so but 😬

Great pleasure to host <a href="/xdopazo/">Joaquin Dopazo</a> from <a href="/FProgresoysalud/">Fundación Progreso y Salud</a> at <a href="/cabimer/">Cabimer</a> last Friday! 🚀
An inspiring talk on how AI is reshaping targeted drug discovery. #AI #DrugDiscovery #Innovation Are we obsolete?? Don't think so but 😬
RosadoLab (@rosadolab) 's Twitter Profile Photo

El contrato para realizar tu tesis doctoral en inestabilidad genetica y procesos tumorales en Anemia de Fanconi ya esta disponible. Solicitala!! Please RT! investigacion.us.es/sisiusapp/open…

El contrato para realizar tu tesis doctoral en inestabilidad genetica y procesos tumorales en Anemia de Fanconi ya esta disponible. Solicitala!! Please RT!

investigacion.us.es/sisiusapp/open…
Cabimer (@cabimer) 's Twitter Profile Photo

📰 La Vanguardia destaca el trabajo del grupo de Benoit Gauthier en CABIMER, que desarrolla una molécula capaz de proteger y regenerar células beta, abriendo nuevas vías terapéuticas contra la diabetes tipo 1. Más info: lnkd.in/dWVBtHeE #CABIMER #Investigación #Diabetes

📰 <a href="/LaVanguardia/">La Vanguardia</a> destaca el trabajo del grupo de Benoit Gauthier en CABIMER, que desarrolla una molécula capaz de proteger y regenerar células beta, abriendo nuevas vías terapéuticas contra la diabetes tipo 1.
Más info: lnkd.in/dWVBtHeE

#CABIMER #Investigación #Diabetes